|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.05 EUR | +0.84% |
|
+3.34% | -4.80% |
| 02:39pm | Moderna Looking to Invest in German Production Sites | MT |
| 01:54pm | Moderna Eyeing German Production Investment With BioNTech Closures, CEO Says | MT |
| Market Cap | 1.95TCr 2.26TCr 1.8TCr 1.69TCr 3.17TCr 2,14000Cr 3.2TCr 21TCr 8.27TCr 1,04800Cr 8.49TCr 8.31TCr 3,63200Cr | P/E 2026 * |
-17.5x | P/E 2027 * | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 865.3Cr 1TCr 796.8Cr 748.12Cr 1.4TCr 95TCr 1.42TCr 9.42TCr 3.67TCr 46TCr 3.77TCr 3.69TCr 1,61100Cr | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 4.58x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 week | +3.34% | ||
| Current month | -5.90% | ||
| 1 month | -0.06% | ||
| 3 months | -1.65% | ||
| 6 months | -1.71% | ||
| Current year | -4.80% |
| 1 week | 73.2 |  | 79.55 |
| 1 month | 73.2 | | 84.9 |
| 3 years | 68.35 | | 124.7 |
| 5 years | 68.35 | | 397 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | +3.34% | -16.05% | -24.85% | 2.26TCr | |
| +1.35% | +0.39% | +62.01% | +112.72% | 5.45TCr | |
| -1.22% | +5.01% | +43.38% | +36.69% | 4.39TCr | |
| -1.99% | -3.55% | -5.97% | +377.60% | 2.07TCr | |
| -0.53% | +0.54% | +16.19% | -36.06% | 1.58TCr | |
| +3.08% | -0.28% | +11.28% | -39.31% | 1.48TCr | |
| -1.70% | -1.68% | +24.79% | +172.92% | 1.31TCr | |
| -5.17% | +0.50% | +21.80% | - | 1.27TCr | |
| +0.29% | +5.10% | +75.82% | +105.33% | 1.16TCr | |
| +4.10% | +0.10% | +108.68% | +226.33% | 1.17TCr | |
| Average | -0.20% | -0.15% | +34.19% | +103.49% | 2.21TCr | |
| Weighted average by Cap. | -0.10% | -0.18% | +35.99% | +95.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 216.59Cr 251.32Cr 199.44Cr 187.26Cr 351.58Cr 24TCr 355.29Cr 2.36TCr 918.12Cr 12TCr 943.17Cr 923.14Cr 40TCr | 223.05Cr 258.82Cr 205.4Cr 192.85Cr 362.07Cr 24TCr 365.9Cr 2.43TCr 945.53Cr 12TCr 971.33Cr 950.71Cr 42TCr |
| Net income | -105.09Cr -121.94Cr -97Cr -91Cr -170.58Cr -12TCr -172.38Cr -1.14TCr -445.46Cr -5.65TCr -457.62Cr -447.9Cr -20TCr | -116.54Cr -135.22Cr -107.31Cr -100.76Cr -189.17Cr -13TCr -191.17Cr -1.27TCr -494Cr -6.26TCr -507.48Cr -496.71Cr -22TCr |
| Net Debt | -1.09TCr -1.26TCr -999.32Cr -938.27Cr -1.76TCr -1,19100Cr -1.78TCr -12TCr -4.6TCr -58TCr -4.73TCr -4.63TCr -2,02000Cr | -928.08Cr -1.08TCr -854.61Cr -802.4Cr -1.51TCr -1,01800Cr -1.52TCr -10TCr -3.93TCr -50TCr -4.04TCr -3.96TCr -1,72800Cr |
| Date | Price | Change |
|---|---|---|
| 17/26/17 | 78.05 € | +0.84% |
| 16/26/16 | 77.40 € | -1.34% |
| 15/26/15 | 78.45 € | +0.71% |
| 12/26/12 | 77.90 € | +0.84% |
| 11/26/11 | 77.25 € | +3.07% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
Select your edition
All financial news and data tailored to specific country editions
